821 related articles for article (PubMed ID: 9973404)
21. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
22. Two different epitopes of the signal transducer gp130 sequentially cooperate on IL-6-induced receptor activation.
Pflanz S; Kurth I; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 2000 Dec; 165(12):7042-9. PubMed ID: 11120832
[TBL] [Abstract][Full Text] [Related]
23. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
Smith DK; Treutlein HR
Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
[TBL] [Abstract][Full Text] [Related]
26. Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors.
Hammacher A; Wijdenes J; Hilton DJ; Nicola NA; Simpson RJ; Layton JE
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):25-32. PubMed ID: 10600635
[TBL] [Abstract][Full Text] [Related]
27. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
28. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
29. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
Yin T; Taga T; Tsang ML; Yasukawa K; Kishimoto T; Yang YC
J Immunol; 1993 Sep; 151(5):2555-61. PubMed ID: 8360477
[TBL] [Abstract][Full Text] [Related]
30. The cytokine receptor gp130: faithfully promiscuous.
Müller-Newen G
Sci STKE; 2003 Sep; 2003(201):PE40. PubMed ID: 14506288
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines.
Aasland D; Schuster B; Grötzinger J; Rose-John S; Kallen KJ
Biochemistry; 2003 May; 42(18):5244-52. PubMed ID: 12731865
[TBL] [Abstract][Full Text] [Related]
32. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes.
Grötzinger J; Kurapkat G; Wollmer A; Kalai M; Rose-John S
Proteins; 1997 Jan; 27(1):96-109. PubMed ID: 9037715
[TBL] [Abstract][Full Text] [Related]
33. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
34. Biosynthetic and glycosylation events of the IL-6 receptor beta-subunit, gp130.
Wang Y; Fuller GM
J Cell Biochem; 1995 Apr; 57(4):610-8. PubMed ID: 7615645
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
36. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
37. Theoretical investigation of IL-6 multiprotein receptor assembly.
Menziani MC; Fanelli F; De Benedetti PG
Proteins; 1997 Dec; 29(4):528-44. PubMed ID: 9408949
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 and related cytokines: effect on the acute phase reaction.
Heinrich PC; Horn F; Graeve L; Dittrich E; Kerr I; Müller-Newen G; Grötzinger J; Wollmer A
Z Ernahrungswiss; 1998; 37 Suppl 1():43-9. PubMed ID: 9558728
[TBL] [Abstract][Full Text] [Related]
39. The soluble IL-6 receptors: serum levels and biological function.
Montero-Julian FA
Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):583-97. PubMed ID: 11502067
[TBL] [Abstract][Full Text] [Related]
40. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]